Seres Therapeutics Inc
F:1S9
Seres Therapeutics Inc
F:1S9
Price:
0.2
EUR
Market Cap:
€30.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Seres Therapeutics Inc
F:1S9
|
US |
|
T
|
Toyota Industries Corp
XBER:TAH
|
JP |
Wall St Price Targets
1S9 Price Targets Summary
Seres Therapeutics Inc
Seres Therapeutics Inc
Wall Street analysts forecast 1S9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1S9 is 0.68 EUR with a low forecast of 0.47 EUR and a high forecast of 0.9 EUR.
Lowest Forecast
Price Target
0.47
EUR
137% Upside
Average Forecast
Price Target
0.68
EUR
239% Upside
Highest Forecast
Price Target
0.9
EUR
352% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S9's stock price target?
Price Target
0.68
EUR
0.68
EUR
According to Wall Street analysts, the average 1-year price target for 1S9 is 0.68 EUR with a low forecast of 0.47 EUR and a high forecast of 0.9 EUR.
What is the Revenue forecast for Seres Therapeutics Inc?
Projected CAGR
-29%
-29%
The compound annual growth rate for Revenue over the next 3 years is -29%.
